US0367521038
US0367521038
Elevance Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 89.5B EUR | 83.86B EUR | 63.63B EUR |
Enterprise Value | 80.62B EUR | 104.67B EUR | 85.82B EUR |
Valuation Multiples | |||
Trailing P/E | 18.27x | 16.9x | 12.14x |
Forward P/E | 13.95x | -- | -- |
Price to Sales | 0.45x | 0.42x | 0.32x |
Price to Book | 1.99x | 1.87x | 1.45x |
EV/Revenue | 0.4x | 0.52x | 0.43x |
EV/EBITDA | 9.69x | -- | -- |
Price to FCF (P/FCF) | 20.78x | 13.33x | 9.87x |
EV/FCF | 18.72x | 16.64x | 13.31x |
FCF Yield | 4.81% | 7.5% | 10.14% |